Retrolaminar Demyelination of Structurally Intact Axons in Nonhuman Primate Experimental Glaucoma.

Journal Information

Full Title: Invest Ophthalmol Vis Sci

Abbreviation: Invest Ophthalmol Vis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: P. Chaudhary, None; H. Lockwood, None; C. Stowell, None; E. Bushong, None; J. Reynaud, None; H. Yang, None; S.K. Gardiner, None; G. Wiliams, None; I. Williams, None; M. Ellisman, None; N. Marsh-Armstrong, None; C. Burgoyne, Heidelberg Engineering (F, R), Reichert (F)"

Evidence found in paper:

"The authors thank their Devers Eye Institute colleagues Brad Fortune and Grant Cull for their assistance with the implementation of the FoBMO sectoral axon count methodology. CB thanks John Crabb, of the Cleveland Clinic, whose preliminary proteomic findings suggested that myelin-related alterations were present in NHP early EG. Supported by NIH R01 EY011610 (CFB), NIH R01 EY029087 (NMA, CFB) American Glaucoma Society (CFB), Sears Trust (CFB), Bright Focus (PC, HY), Alcon Research Institute (PC, CFB), and Legacy Good Samaritan Foundation–Devers Eye Institute Endowment (CFB)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025